Remove Advocacy Remove Clinical Trials Remove Data Remove Pharmaceutical
article thumbnail

Marinus Pharmaceuticals Announces New Clinical and Research Data to be Presented at American Epilepsy Society Meeting

Cannabis Law Report

–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Chief Executive Officer of Marinus Pharmaceuticals. “We Chief Executive Officer of Marinus Pharmaceuticals. “We RADNOR, Pa.–(BUSINESS Additionally, improved developmental outcomes may lead to improved patient quality of life.

article thumbnail

Veriheal’s Innovation in Cannabis Scholarship 2020 Winners

Veriheal

He was exposed to alternative herbal options during his volunteer work as a Spanish interpreter at migrant clinics, and he became interested in medical cannabis when his mother asked him about CBD oil and cannabis as alternative options for her daily shoulder pain. . Personal data and information would be anonymous.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

A Hidden Origin Story of the CBD Craze

SMPL

And because CBD doesn’t get you high, it was easy to miss; hardly anyone outside of pharmaceutical companies and academia had heard of it. Mr. Gardner, the writer whose CBD advocacy eventually inspired the 2011 summit at Ms. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex.

CBD 40
article thumbnail

Psychedelic Invest’s 100 Most Influential People in Psychedelics List

Cannabis Law Report

Rick, and MAPS, have published hundreds of research papers, articles, and reports over the past several decades in addition to participation in dozens of clinical trials and international studies. Healing Advocacy Fund. Jonathan is the CEO and founder of Gilgamesh Pharmaceuticals. Rick Doblin, Ph.D, in/rickdoblin/ [link].

article thumbnail

Cannabis in Israel, with Itai Rogel

The Cannigma

Listen & Subscribe: Israel is world-renowned for the research and innovation that is taking place there, and unofficial data suggests that around 20% of the Israeli population uses cannabis. We do participate in clinical trials that are initiated by others, and we will have our own clinical trial using terpene formulations in oil.

article thumbnail

Paper: The transition of cannabis into the mainstream of Australian healthcare: framings in professional medical publications

Cannabis Law Report

At the same time, the outlook on cannabis research data is largely positive. Data collection. One coder then independently coded the entire dataset and entered the data into NVivo v12. This offers a more denotative approach to complement the data. The coding method was a combination of deductive and inductive codes.